Trident Texofab Forfeits Warrants Worth ₹1.59 Cr

Trident Texofab Ltd has announced the forfeiture of 9,11,479 fully convertible warrants, representing 25% of the upfront consideration paid by certain warrant holders. These warrants, originally allotted on December 23, 2024, with an exercise price of ₹70 each, lapsed as the holders failed to exercise their option to convert them into equity shares within the stipulated 18-month period, which ended on June 22, 2026. The forfeited amount totals ₹1,59,50,882.50. Consequently, all outstanding warrants have lapsed and stand cancelled. The company stated that this action has not resulted in any change to its issued, subscribed, or paid-up equity share capital.